Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights

Oct 1, 2025
by Keith Speights
Investing in Biotech Stocks in 2025

Sep 30, 2025
by Keith Speights
Investing in Gene-Editing Stocks

Sep 29, 2025
by Keith Speights
Biotech vs. Pharma: What's the Difference?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.